Atnaujinta: 2024.11.26 13:21 (GMT+2)

Tallinna Farmaatsiatehas: Balance sheet as of 30.09.2000

2000.11.07, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

BALANCE SHEET AS OF 30.09.2000

thousand EEK 30.09.2000 31.12.1999

A S S E T S

CURRENT ASSETS
Cash and bank accounts 2 060 1 782
Customer receivables
ACCOUNTS RECEIVABLE 3 104 3 443
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE -327 -
Total 2 776 3 443

Other receivables
RECEIVABLES FROM PARENT COMPANY 23 953 22 601
OTHER SHORT-TERM RECEIVABLES 1 199 3 048
Total 25 152 25 649

Accrued income 37 37
Prepaid expenses 323 473
Inventories
RAW MATERIAL 11 815 12 380
WORK-IN-PROGRESS 1 293 879
FINISHED GOODS 16 082 12 415
PREPAYMENTS TO SUPPLIERS 419 1 266
Total 29 610 26 940

TOTAL CURRENT ASSETS 59 957 58 324

NON-CURRENT ASSETS
Long-term investments 484 480

Fixed assets
FIXED ASSETS IN NET BOOK VALUE 31 443 33 561
CONSTRUCTION IN PROGRESS 3 222 1 344
Total 34 665 34 905

Intangible assets 2 667 3 218

TOTAL NON-CURRENT ASSETS 37 816 38 604

TOTAL ASSETS 97 773 96 928



LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 2 333 7 703
SHORT-TERM BANK LOANS - 418
Total 2 333 8 121

Customers prepayments - 44
Accounts payable 12 449 13 130
Other payables 258 1 006
Taxes payable 976 1 575
Accrued expenses 2 156 1 969

TOTAL CURRENT LIABILITIES 18 172 25 846

NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 32 254 30 812
PAYABLES TO PARENT COMPANY 28 232 28 232
TOTAL NON-CURRENT LIABILITIES 60 487 59 044
TOTAL LIABILITIES 78 659 84 890

SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12 500 12 500
RESERVES 2 316 2 316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2 779 -8 560
PROFIT (LOSS) FOR FINANCIAL YEAR 7 076 5 782
SHAREHOLDERS’ EQUITY TOTAL 19 114 12 037

LIABILITIES AND SHAREHOLDERS’ EQUITY 97 773 96 928


Raivo Unt
Financial Director
+372 61 20 201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai